Article info
Original Article
Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation
- Professor S Grisanti, Department of Ophthalmology at the University of Luebeck, Luebeck Germany, Ratzeburger Allee 160, 23538 Luebeck, Germany; salvatore.grisanti{at}uk-sh.de
Citation
Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation
Publication history
- Accepted September 17, 2008
- First published October 6, 2008.
Online issue publication
February 09, 2022
Article Versions
- Previous version (22 March 2016).
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group